TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) is one of 236 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it compare to its competitors? We will ...
According to data from the phase 3 double-blinded, active-controlled, multicenter LEAP-012 trial (NCT04246177), lenvatinib (Lenvima) with pembrolizumab (Keytruda) and transarterial chemoembolization ...